THBS4 and proximal spinal muscular atrophy: Consequently, we postulate that TSP4 levels in CSF may serve as a promising therapeutic biomarker of pathophysiological relevance in children suffering from SMA and hereby even enable to distinguish between clinically affected and non-affected patients in terms of a therapy marker.